お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はHIV検査市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはHIV検査の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のHIV検査市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはHIV検査のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にHIV検査市場を分類しています。本研究に含まれる主な企業は：Abbott、Affymetrix、Beckman Coulter/Danaher、Becton Dickinson、bioMerieux、Bio-Rad、Cepheid、Diamedix、DiaSorin、Eiken Chemical、Elitech Group、Enzo Biochem、Fujirebio、Lonza、Roche、Scienion、Sequenom、SeraCare、Siemens、Takara Bio

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Kits and Reagents
    Instruments
    Others

用途別の市場セグメント：
    Hospitals
    Private Diagnostics Laboratories
    Academic and Research Institutes
    Others

本レポートの詳細内容
世界のHIV検査市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、HIV検査タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のHIV検査収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のHIV検査市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、HIV検査市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

HIV検査のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：HIV検査のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：HIV検査の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章HIV検査企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：HIV検査の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：HIV検査の主要企業の概要を提供し、製品の説明と仕様、HIV検査の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

HIV-AIDS is a chronic disease caused by the human immunodeficiency virus (HIV). HIV virus damages human immune system, which results weakness of immune system and loss ability to fight with organism that causes disease.
HIV-AIDS most often spread through unprotected sex with HIV infected person. In addition, HIV-AIDS can also be spread from infected mother to child during pregnancy, infected blood and sharing needles with someone who has HIV-AIDS. Some of the symptoms of HIV include slight fever, swollen glands, muscle aches, headaches and fatigue.
Market Analysis and Insights: Global HIV-AIDS Testing Market
The global HIV-AIDS Testing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for HIV-AIDS Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for HIV-AIDS Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for HIV-AIDS Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of HIV-AIDS Testing include Abbott, Affymetrix, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, Diamedix and DiaSorin, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
HIV-AIDS Testing is widely used in various fields, such as Hospitals, Private Diagnostics Laboratories, Academic and Research Institutes and Others, etc. Hospitals provides greatest supports to the HIV-AIDS Testing industry development. In 2023, global % revenue of HIV-AIDS Testing went into Hospitals filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for HIV-AIDS Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of HIV-AIDS Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for HIV-AIDS Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the HIV-AIDS Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global HIV-AIDS Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for HIV-AIDS Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, Affymetrix, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, Diamedix and DiaSorin, etc.

Market Segmentation
By Company
    Abbott
    Affymetrix
    Beckman Coulter/Danaher
    Becton Dickinson
    bioMerieux
    Bio-Rad
    Cepheid
    Diamedix
    DiaSorin
    Eiken Chemical
    Elitech Group
    Enzo Biochem
    Fujirebio
    Lonza
    Roche
    Scienion
    Sequenom
    SeraCare
    Siemens
    Takara Bio

Segment by Type
    Kits and Reagents
    Instruments
    Others

Segment by Application
    Hospitals
    Private Diagnostics Laboratories
    Academic and Research Institutes
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of HIV-AIDS Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV-AIDS Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HIV-AIDS Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global HIV-AIDS Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Kits and Reagents
    Table 3. Key Players of Instruments
    Table 4. Key Players of Others
    Table 5. Global HIV-AIDS Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global HIV-AIDS Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global HIV-AIDS Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global HIV-AIDS Testing Market Share by Region (2019-2024)
    Table 9. Global HIV-AIDS Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global HIV-AIDS Testing Market Share by Region (2025-2030)
    Table 11. HIV-AIDS Testing Market Trends
    Table 12. HIV-AIDS Testing Market Drivers
    Table 13. HIV-AIDS Testing Market Challenges
    Table 14. HIV-AIDS Testing Market Restraints
    Table 15. Global HIV-AIDS Testing Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global HIV-AIDS Testing Revenue Share by Players (2019-2024)
    Table 17. Global Top HIV-AIDS Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV-AIDS Testing as of 2023)
    Table 18. Global HIV-AIDS Testing Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by HIV-AIDS Testing Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of HIV-AIDS Testing, Headquarters and Area Served
    Table 21. Global Key Players of HIV-AIDS Testing, Product and Application
    Table 22. Global Key Players of HIV-AIDS Testing, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global HIV-AIDS Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global HIV-AIDS Testing Revenue Market Share by Type (2019-2024)
    Table 26. Global HIV-AIDS Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global HIV-AIDS Testing Revenue Market Share by Type (2025-2030)
    Table 28. Global HIV-AIDS Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global HIV-AIDS Testing Revenue Share by Application (2019-2024)
    Table 30. Global HIV-AIDS Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global HIV-AIDS Testing Revenue Share by Application (2025-2030)
    Table 32. North America HIV-AIDS Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America HIV-AIDS Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America HIV-AIDS Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America HIV-AIDS Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America HIV-AIDS Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America HIV-AIDS Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America HIV-AIDS Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe HIV-AIDS Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe HIV-AIDS Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe HIV-AIDS Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe HIV-AIDS Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe HIV-AIDS Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe HIV-AIDS Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe HIV-AIDS Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China HIV-AIDS Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China HIV-AIDS Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China HIV-AIDS Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China HIV-AIDS Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia HIV-AIDS Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia HIV-AIDS Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia HIV-AIDS Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia HIV-AIDS Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia HIV-AIDS Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia HIV-AIDS Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia HIV-AIDS Testing Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America HIV-AIDS Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America HIV-AIDS Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America HIV-AIDS Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America HIV-AIDS Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America HIV-AIDS Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America HIV-AIDS Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America HIV-AIDS Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Abbott Company Details
    Table 65. Abbott Business Overview
    Table 66. Abbott HIV-AIDS Testing Product
    Table 67. Abbott Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 68. Abbott Recent Developments
    Table 69. Affymetrix Company Details
    Table 70. Affymetrix Business Overview
    Table 71. Affymetrix HIV-AIDS Testing Product
    Table 72. Affymetrix Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 73. Affymetrix Recent Developments
    Table 74. Beckman Coulter/Danaher Company Details
    Table 75. Beckman Coulter/Danaher Business Overview
    Table 76. Beckman Coulter/Danaher HIV-AIDS Testing Product
    Table 77. Beckman Coulter/Danaher Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 78. Beckman Coulter/Danaher Recent Developments
    Table 79. Becton Dickinson Company Details
    Table 80. Becton Dickinson Business Overview
    Table 81. Becton Dickinson HIV-AIDS Testing Product
    Table 82. Becton Dickinson Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 83. Becton Dickinson Recent Developments
    Table 84. bioMerieux Company Details
    Table 85. bioMerieux Business Overview
    Table 86. bioMerieux HIV-AIDS Testing Product
    Table 87. bioMerieux Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 88. bioMerieux Recent Developments
    Table 89. Bio-Rad Company Details
    Table 90. Bio-Rad Business Overview
    Table 91. Bio-Rad HIV-AIDS Testing Product
    Table 92. Bio-Rad Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 93. Bio-Rad Recent Developments
    Table 94. Cepheid Company Details
    Table 95. Cepheid Business Overview
    Table 96. Cepheid HIV-AIDS Testing Product
    Table 97. Cepheid Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 98. Cepheid Recent Developments
    Table 99. Diamedix Company Details
    Table 100. Diamedix Business Overview
    Table 101. Diamedix HIV-AIDS Testing Product
    Table 102. Diamedix Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 103. Diamedix Recent Developments
    Table 104. DiaSorin Company Details
    Table 105. DiaSorin Business Overview
    Table 106. DiaSorin HIV-AIDS Testing Product
    Table 107. DiaSorin Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 108. DiaSorin Recent Developments
    Table 109. Eiken Chemical Company Details
    Table 110. Eiken Chemical Business Overview
    Table 111. Eiken Chemical HIV-AIDS Testing Product
    Table 112. Eiken Chemical Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 113. Eiken Chemical Recent Developments
    Table 114. Elitech Group Company Details
    Table 115. Elitech Group Business Overview
    Table 116. Elitech Group HIV-AIDS Testing Product
    Table 117. Elitech Group Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 118. Elitech Group Recent Developments
    Table 119. Enzo Biochem Company Details
    Table 120. Enzo Biochem Business Overview
    Table 121. Enzo Biochem HIV-AIDS Testing Product
    Table 122. Enzo Biochem Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 123. Enzo Biochem Recent Developments
    Table 124. Fujirebio Company Details
    Table 125. Fujirebio Business Overview
    Table 126. Fujirebio HIV-AIDS Testing Product
    Table 127. Fujirebio Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 128. Fujirebio Recent Developments
    Table 129. Lonza Company Details
    Table 130. Lonza Business Overview
    Table 131. Lonza HIV-AIDS Testing Product
    Table 132. Lonza Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 133. Lonza Recent Developments
    Table 134. Roche Company Details
    Table 135. Roche Business Overview
    Table 136. Roche HIV-AIDS Testing Product
    Table 137. Roche Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 138. Roche Recent Developments
    Table 139. Scienion Company Details
    Table 140. Scienion Business Overview
    Table 141. Scienion HIV-AIDS Testing Product
    Table 142. Scienion Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 143. Scienion Recent Developments
    Table 144. Sequenom Company Details
    Table 145. Sequenom Business Overview
    Table 146. Sequenom HIV-AIDS Testing Product
    Table 147. Sequenom Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 148. Sequenom Recent Developments
    Table 149. SeraCare Company Details
    Table 150. SeraCare Business Overview
    Table 151. SeraCare HIV-AIDS Testing Product
    Table 152. SeraCare Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 153. SeraCare Recent Developments
    Table 154. Siemens Company Details
    Table 155. Siemens Business Overview
    Table 156. Siemens HIV-AIDS Testing Product
    Table 157. Siemens Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 158. Siemens Recent Developments
    Table 159. Takara Bio Company Details
    Table 160. Takara Bio Business Overview
    Table 161. Takara Bio HIV-AIDS Testing Product
    Table 162. Takara Bio Revenue in HIV-AIDS Testing Business (2019-2024) & (US$ Million)
    Table 163. Takara Bio Recent Developments
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global HIV-AIDS Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global HIV-AIDS Testing Market Share by Type: 2023 VS 2030
    Figure 3. Kits and Reagents Features
    Figure 4. Instruments Features
    Figure 5. Others Features
    Figure 6. Global HIV-AIDS Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global HIV-AIDS Testing Market Share by Application: 2023 VS 2030
    Figure 8. Hospitals Case Studies
    Figure 9. Private Diagnostics Laboratories Case Studies
    Figure 10. Academic and Research Institutes Case Studies
    Figure 11. Others Case Studies
    Figure 12. HIV-AIDS Testing Report Years Considered
    Figure 13. Global HIV-AIDS Testing Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global HIV-AIDS Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global HIV-AIDS Testing Market Share by Region: 2023 VS 2030
    Figure 16. Global HIV-AIDS Testing Market Share by Players in 2023
    Figure 17. Global Top HIV-AIDS Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV-AIDS Testing as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by HIV-AIDS Testing Revenue in 2023
    Figure 19. North America HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America HIV-AIDS Testing Market Share by Type (2019-2030)
    Figure 21. North America HIV-AIDS Testing Market Share by Application (2019-2030)
    Figure 22. North America HIV-AIDS Testing Market Share by Country (2019-2030)
    Figure 23. United States HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe HIV-AIDS Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe HIV-AIDS Testing Market Share by Type (2019-2030)
    Figure 27. Europe HIV-AIDS Testing Market Share by Application (2019-2030)
    Figure 28. Europe HIV-AIDS Testing Market Share by Country (2019-2030)
    Figure 29. Germany HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China HIV-AIDS Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China HIV-AIDS Testing Market Share by Type (2019-2030)
    Figure 37. China HIV-AIDS Testing Market Share by Application (2019-2030)
    Figure 38. Asia HIV-AIDS Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia HIV-AIDS Testing Market Share by Type (2019-2030)
    Figure 40. Asia HIV-AIDS Testing Market Share by Application (2019-2030)
    Figure 41. Asia HIV-AIDS Testing Market Share by Region (2019-2030)
    Figure 42. Japan HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America HIV-AIDS Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America HIV-AIDS Testing Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America HIV-AIDS Testing Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America HIV-AIDS Testing Market Share by Country (2019-2030)
    Figure 52. Brazil HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries HIV-AIDS Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Abbott Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 59. Affymetrix Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 60. Beckman Coulter/Danaher Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 61. Becton Dickinson Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 62. bioMerieux Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 63. Bio-Rad Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 64. Cepheid Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 65. Diamedix Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 66. DiaSorin Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 67. Eiken Chemical Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 68. Elitech Group Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 69. Enzo Biochem Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 70. Fujirebio Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 71. Lonza Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 72. Roche Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 73. Scienion Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 74. Sequenom Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 75. SeraCare Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 76. Siemens Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 77. Takara Bio Revenue Growth Rate in HIV-AIDS Testing Business (2019-2024)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed